Kirk U. Knowlton

12.5k total citations · 2 hit papers
157 papers, 6.8k citations indexed

About

Kirk U. Knowlton is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Kirk U. Knowlton has authored 157 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Cardiology and Cardiovascular Medicine, 41 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Kirk U. Knowlton's work include Viral Infections and Immunology Research (33 papers), Cardiomyopathy and Myosin Studies (27 papers) and Cardiac Imaging and Diagnostics (16 papers). Kirk U. Knowlton is often cited by papers focused on Viral Infections and Immunology Research (33 papers), Cardiomyopathy and Myosin Studies (27 papers) and Cardiac Imaging and Diagnostics (16 papers). Kirk U. Knowlton collaborates with scholars based in United States, Germany and Japan. Kirk U. Knowlton's co-authors include Kenneth R. Chien, Cornel Badorff, Joan Heller Brown, Shu Chien, Guoqi Zhu, Toshitaka Yajima, Rainer Wessely, H E Shubeita, Adrienne N. Harris and C C Glembotski and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kirk U. Knowlton

147 papers receiving 6.7k citations

Hit Papers

Regulation of cardiac gene expression during myocardial g... 1990 2026 2002 2014 1991 1990 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirk U. Knowlton United States 39 4.4k 3.4k 684 652 562 157 6.8k
Giulia d’Amati Italy 45 1.9k 0.4× 2.4k 0.7× 435 0.6× 458 0.7× 686 1.2× 212 6.2k
Michael A. Crackower United States 28 1.9k 0.4× 2.9k 0.8× 416 0.6× 487 0.7× 342 0.6× 42 6.9k
Uwe Lendeckel Germany 46 2.3k 0.5× 2.1k 0.6× 473 0.7× 410 0.6× 412 0.7× 186 6.4k
Roger E. Breitbart United States 32 2.6k 0.6× 3.1k 0.9× 431 0.6× 883 1.4× 1.8k 3.3× 49 8.7k
Glenn I. Fishman United States 61 4.5k 1.0× 7.7k 2.3× 273 0.4× 526 0.8× 557 1.0× 136 11.1k
Weidong Zhu China 30 1.3k 0.3× 2.3k 0.7× 343 0.5× 547 0.8× 605 1.1× 102 4.3k
Raj Kishore United States 49 1.5k 0.3× 4.3k 1.3× 1.1k 1.6× 454 0.7× 494 0.9× 143 7.1k
Monika Stoll Germany 40 2.0k 0.5× 2.1k 0.6× 766 1.1× 474 0.7× 433 0.8× 167 5.9k
Michael T. Crow United States 51 2.3k 0.5× 4.8k 1.4× 839 1.2× 885 1.4× 607 1.1× 103 8.8k
Yohan Bossé Canada 48 2.7k 0.6× 2.2k 0.7× 830 1.2× 1.1k 1.7× 1.5k 2.7× 219 7.9k

Countries citing papers authored by Kirk U. Knowlton

Since Specialization
Citations

This map shows the geographic impact of Kirk U. Knowlton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk U. Knowlton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk U. Knowlton more than expected).

Fields of papers citing papers by Kirk U. Knowlton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk U. Knowlton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk U. Knowlton. The network helps show where Kirk U. Knowlton may publish in the future.

Co-authorship network of co-authors of Kirk U. Knowlton

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk U. Knowlton. A scholar is included among the top collaborators of Kirk U. Knowlton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk U. Knowlton. Kirk U. Knowlton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knowlton, Kirk U., Ann Marie Návar, Jeffrey Anderson, et al.. (2025). LDL-C management with inclisiran plus usual care vs usual care alone in participants with recent acute coronary syndrome: VICTORION-INCEPTION. Journal of clinical lipidology. 19(3). e109–e110. 2 indexed citations
2.
Horne, Benjamin D., Jeffrey L. Anderson, Heidi T. May, et al.. (2025). Weight loss-independent changes in human growth hormone during water-only fasting: a secondary evaluation of a randomized controlled trial. Frontiers in Endocrinology. 15. 1401780–1401780. 1 indexed citations
3.
6.
Anderson, Jeffrey L., Stacey Knight, Heidi T. May, et al.. (2023). Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience. Journal of Clinical Medicine. 12(9). 3263–3263. 3 indexed citations
7.
Horne, Benjamin D., Heidi T. May, Joseph B. Muhlestein, et al.. (2022). Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry. BMJ Nutrition Prevention & Health. 5(2). 145–153. 12 indexed citations
8.
Horne, Benjamin D., Joseph Bledsoe, Joseph B. Muhlestein, et al.. (2022). Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort. BMJ Open. 12(3). e053864–e053864. 1 indexed citations
9.
Horne, Benjamin D., Joseph B. Muhlestein, Heidi T. May, et al.. (2021). Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial. Nutrients. 13(12). 4407–4407. 3 indexed citations
10.
Knowlton, Kirk U.. (2020). Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus. Journal of Molecular and Cellular Cardiology. 147. 12–17. 24 indexed citations
11.
Le, Viet T., Kirk U. Knowlton, Raymond O. McCubrey, et al.. (2019). Abstract 11700: Higher Plasma EPA, EPA/AA and DHA Levels Are Associated With Lower Incident MACE Both in Those With and Without Angiographic CAD. Circulation. 1 indexed citations
12.
May, Heidi T., Kirk U. Knowlton, Jeffrey L. Anderson, et al.. (2019). IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, HIGH STATIN ADHERENCE OVER 5 YEARS OF FOLLOW-UP IS ASSOCIATED WITH IMPROVED CARDIOVASCULAR OUTCOMES: RESULTS FROM THE IMPRES STUDY. Journal of the American College of Cardiology. 73(9). 98–98. 1 indexed citations
13.
Trifilo, Matthew J., Toshitaka Yajima, Yusu Gu, et al.. (2006). Prion-Induced Amyloid Heart Disease with High Blood Infectivity in Transgenic Mice. Science. 313(5783). 94–97. 49 indexed citations
14.
Bang, Marie‐Louise, Xiaodong Li, Ryan Littlefield, et al.. (2006). Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle. The Journal of Cell Biology. 173(6). 905–916. 168 indexed citations
16.
DeMaria, Anthony N., Ori Ben‐Yehuda, Daniel S. Berman, et al.. (2004). Highlights of the year in JACC2004. Journal of the American College of Cardiology. 45(1). 137–153. 2 indexed citations
17.
DeMaria, Anthony N., Ori Ben‐Yehuda, Gregory K. Feld, et al.. (2003). Highlights of the year in JACC2003. Journal of the American College of Cardiology. 42(12). 2156–2166. 1 indexed citations
18.
Ryoke, Tsutomu, Yusu Gu, Yasuhiro Ikeda, et al.. (2002). Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster. Basic Research in Cardiology. 97(1). 65–75. 17 indexed citations
20.
Maisel, Alan S., Kirk U. Knowlton, Ann Rearden, et al.. (1990). Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment.. Journal of Clinical Investigation. 85(2). 462–467. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026